Cited by 289Iron Metabolism and DisordersMetal complexes synthesis and propertiesInorganic and Organometallic Chemistry

The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.

Design of iron chelators with therapeutic application

Liu, Zu D, Hider, Robert C·2002·Coordination Chemistry Reviews

DOI 10.1016/s0010-8545(02)00050-4

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s0010-8545(02)00050-4

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Critical Stability Constants
Martell, A. E., & Smith, R. M. (1982) · Springer eBooks · doi:10.1007/978-1-4615-6761-5 · Cited by 6,025
Free Radicals in Biology and Medicine
Land, E. J. (1990) · International Journal of Radiation Biology · doi:10.1080/09553009014552071 · Cited by 4,871
Disorders of Iron Metabolism
Andrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
Hematology: Basic Principles and Practice
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-238_2 · Cited by 1,862
Undetectable Intracellular Free Copper: The Requirement of a Copper Chaperone for Superoxide Dismutase
Rae, T., Schmidt, P. J., Pufahl, R. A., Culotta, V., & O’Halloran, T. V. (1999) · Science · doi:10.1126/science.284.5415.805 · Cited by 1,640
Principles of bioinorganic chemistry
(1995) · Choice Reviews Online · doi:10.5860/choice.32-4515 · Cited by 1,538
Principles of bioinorganic chemistry
Chayen, J. (1995) · Cell Biochemistry and Function · doi:10.1002/cbf.290130214 · Cited by 1,060
Increased nigral iron content in postmortem parkinsonian brain
Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963
Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability
Levin, V. A. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00180a022 · Cited by 817

Show all 132 references

Research works printed but not linked: 27

Pearson, 1963, J. Am. Chem. Soc., 85, 3535
Grady, 1976, J. Pharmacol. Exp. Ther., 196, 478
Winston, 1985, J. Pharmacol. Exp. Ther., 232, 644
Tilbrook, 1998, 35, 691
Holander, 1988, Can. J. Gastroenterol., 2, 35A
Yokel, 1995, Drug Metab. Dispos., 23, 1178
Hider, 1999, Blood, 94, 406A
Hider, 1992, Proc. R. Soc. Edinburgh, 99B, 137
Hershko, 1978, J. Lab. Clin. Med., 92, 144
Pippard, 1978, Clin. Sci. Mol. Med., 54, 99
Freedman, 1990, Am. J. Dis. Child, 144, 565
Lau, 1983, J. Lab. Clin. Med., 101, 806
R. Lattmann, P. Acklin, P. Buhlmayer, A. Crowe, B. Faller, Y. Jin, D. Ledergerber, H.P. Nick, T. Sergejew, C. Spanka, A. Wong, P. Zbinden, H.P. Schnebli, 11th International Conference on Oral Chelation in the Treatment of Thalassaemia, Catania, Italy, 22–25 March 2001, p. 89.
Hershko, 1981, J. Lab. Clin. Med., 98, 99
Johnson, 1982, J. Pharmacol. Exp. Ther., 221, 399
Brittenham, 1990, Semin. Hematol., 27, 112
Webb, 1988, Birth Defects Original Article Ser., 23, 63
Wolfe, 1990, Sem. Haematol., 27, 117
Singh, 1992, Drug Metab. Dispos., 20, 256
Maggio, 1999, Blood, 94, 34B
Cohen, 1999, Blood, 94, 406A
Lu, 2000, Drug Metab. Dispos., 28, 873
Liu, 2000, Arzneim-Forsch/Drug Res., 50, 461
Choudhury, 1997, Drug Metab. Dispos., 25, 332
P. Zbinden, US Patent 5,688,815 (1997).
Hider, 1992, Proc. R. Soc. Edinburgh, 99B, 137
Hoyes, 1992, Cancer Res., 52, 4591

Sorted by citations

Items 201–289 of 289

New methodology for the preparation of 3-hydroxy-2-pyridinone (3,2-HOPO) chelators and extractants. Part 2: Reactions of alcohols, phenols, and thiols with an electrophilic 3,2-HOPO reagent
Chittamuru, S., Lambert, T. N., Martinez, G. M., Jacobs, H. K., & Gopalan, A. S. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.11.128 · Cited by 8
Ligand Design to Target and Modulate Metal–Protein Interactions in Neurodegenerative Diseases
Beck, M. W., Pithadia, A. S., DeToma, A. S., Korshavn, K. J., & Lim, M. H. (2014) · Wiley eBooks · doi:10.1002/9781118697191.ch10 · Cited by 8
The Chemical Basis of Biological Redox Control
Jacob, C., Doering, M., & Burkholz, T. (2009) · Wiley eBooks · doi:10.1002/9783527627585.ch4 · Cited by 8
Synthesis of the trans-fusarinine scaffold
Bertrand, S., Duval, O., Hélesbeux, J., Larcher, G., & Richomme, P. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.02.058 · Cited by 7
Advances in Evaluation of Antioxidant and Toxicological Properties of Stryphnodendron rotundifolium Mart. in Drosophila melanogaster Model
Salazar, G. J. T., Ecker, A., Adefegha, S. A., & da Costa, J. G. M. (2022) · Foods · doi:10.3390/foods11152236 · Cited by 7
Hydroxypyri(mi)dine-Based Chelators as Antidotes of Toxicity Due to Aluminum and Actinides
Santos, M. A., Esteves, M. A., & Chaves, S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800609779 · Cited by 7
Antioxidant Assays
Charles, D. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4310-0_2 · Cited by 9
Complexing Power of Vitamin D3 Toward Various Metals. Potentiometric Studies of Vitamin D3 Complexes with Al3+, Cd2+, Gd3+, and Pb2+ Ions in Water–Ethanol Solution
Mercê, A. L. R., Yano, L. S., Khan, M. A., Thanh, X. D., & Bouet, G. (2003) · Journal of Solution Chemistry · doi:10.1023/b:josl.0000023922.74448.52 · Cited by 7
Diversity in the Interaction of Amino Acid- and Peptide-Based Hydroxamic Acids with Some Platinum Group Metals in Solution
Bíró, L., Buglyó, P., & Farkas, E. (2022) · Molecules · doi:10.3390/molecules27030669 · Cited by 6
pFe 3+ determination of multidentate ligands by a fluorescence assay
Ma, Y., Zhou, T., & Hider, R. C. (2015) · The Analyst · doi:10.1039/c5an00123d · Cited by 6
Self-citation
Combined administration of membrane-permeable and impermeable iron-chelating drugs attenuates ischemia/reperfusion-induced hepatic injury
Mantelou, A. G., Barbouti, A., GOUSSIA, A. C., Zacharioudaki, A., Papoudou‐Bai, A., Vlachou, C., Kokkoris, S., Papalois, A. E., Galaris, D., & Glantzounis, G. K. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.10.266 · Cited by 6
Transmetalation in Cancer Pharmacology
Dharmasivam, M., & Kaya, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211008 · Cited by 5
Study of the effect of thiourea and N-ethyl groups on antibacterial activity of rhodamine-labeled 3,4-HPO iron chelators against Gram (+/−) bacteria
Moniz, T., Feio, M. J., SILVA, D. N. N. D., de Castro, B., & Rangel, M. (2018) · Medicinal Chemistry Research · doi:10.1007/s00044-018-2165-1 · Cited by 5
Comparative Studies on Prussian Blue or Diaquatetraaminecobalt(III) Promoted Hydrolysis of 4-Nitrophenylphosphate in Microemulsions
Tafesse, F. (2003) · International Journal of Molecular Sciences · doi:10.3390/i4060362 · Cited by 5
BIOLOGICAL APPLICATION OF SCHIFF BASE AND ITS METAL COMPLEXES – A REVIEW
(2023) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets31955 · Cited by 5
Synthesis, physicochemical characterization and neuroprotective evaluation of novel 1-hydroxypyrazin-2(1 H )-one iron chelators in an in vitro cell model of Parkinson's disease
Lewis, F. W., Bird, K., Navarro, J.-P., Fallah, R. E., Brandel, J., Hubscher‐Bruder, V., Tsatsanis, A., Duce, J. A., Tétard, D., Bourne, S., et al. (2022) · Dalton Transactions · doi:10.1039/d1dt02604f · Cited by 5
Epoxidation of strained alkenes catalysed by (1,2-dimethyl-4(1H)pyridinone-3-olate)2MnIIICl
Robinson-Miller, A., Wyatt, M. F., & Tétard, D. (2014) · Journal of Molecular Catalysis A Chemical · doi:10.1016/j.molcata.2014.12.012 · Cited by 5
Synthesis and spectroscopic characterization of a new tripodal hexadentate iron chelator incorporating catechol units
Queirós, C., Leite, A., Silva, A. M. G., Gameiro, P., de Castro, B., & Rangel, M. (2014) · Polyhedron · doi:10.1016/j.poly.2014.10.003 · Cited by 5
Determination of divalent trace metals in a soil sample using electrospray ionization mass spectrometry
Hotta, H., Kogure, Y., & Tsunoda, K. (2012) · Analytical Methods · doi:10.1039/c2ay05898g · Cited by 5
Kinetics and Mechanism of the Formation of (1,5)bis(2-hydroxybenzamido)3- azapentaneiron(III) and its Reactions with Thiocyanate, Azide, Acetate, Sulfur(IV) and Ascorbic Acid in Solution, and the Synthesis and Characterization of (nitrato)bis- (2-hydroxybenzamido)3-azapentaneiron(III). The Role of Phenol–amide–amine Coordination
Nayak, S., Dash, A. C., Nayak, P. K., & Das, D. (2005) · Transition Metal Chemistry · doi:10.1007/s11243-005-5627-5 · Cited by 5
Water & O ‐Donor Ligands
Ogden, M. I., & Beer, P. D. (2005) · Encyclopedia of Inorganic Chemistry · doi:10.1002/0470862106.ia255 · Cited by 5
One-Pot Synthesis of Fe(III)-Curcumin Coordination Polymer Nanoparticles with Dynamic Disassembly and Elimination Abilities for Cancer Therapy
Cao, Y., Zhang, X., Ren, B., & Yang, X. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c02158 · Cited by 4
3-Hydroxyquinolin-2-Ones Act as Dual Inhibitors of Ferroptosis and Monoamine Oxidase B: Reducing Alzheimer’s Disease-Related Amyloid Precursor Protein and Hyperphosphorylated Tau In Vivo
Lv, Y., Song, X., He, J., Jiang, X., Lu, L., Fan, M., Guo, Z., Zhang, C., & Xie, Y. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00502 · Cited by 4
Recent advances in therapeutical applications of the versatile hydroxypyridinone chelators
Sharma, S., Baral, M., & Kanungo, B. K. (2022) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1007/s10847-021-01114-1 · Cited by 4
Synthetic approaches to mixed ligand chelators on tert-butylphenol–formaldehyde oligomer (PFO) platforms
Young, J. A., Karmakar, S., Jacobs, H. K., & Gopalan, A. S. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.09.032 · Cited by 4
Safety and efficacy of a novel iron chelator (HBED; (N,N′‐Di(2‐hydroxybenzyl)ethylenediamine‐N,N′‐diacetic acid)) in equine (Equus caballus) as a model for black rhinoceros (Diceros bicornis)
Sullivan, K. E., Lavin, S. R., Livingston, S. E., Knutson, M. D., Valdes, E. V., & Warren, L. K. (2022) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13745 · Cited by 4
N-Based Polydentate Ligands and Corresponding Zn(II) Complexes: A Structural and Spectroscopic Study
Volpi, G., Zago, S., Rabezzana, R., Diana, E., Priola, E., Garino, C., & Gobetto, R. (2023) · Inorganics · doi:10.3390/inorganics11110435 · Cited by 4
Enhancement of growth media for extreme iron limitation in Escherichia coli
Southwell, J. W., Wilson, K. S., Thomas, G. H., & Duhme‐Klair, A. (2024) · Access Microbiology · doi:10.1099/acmi.0.000735.v4 · Cited by 4
Preparation of 3-benzyloxy-2-pyridinone functional linkers: tools for the synthesis of 3,2-hydroxypyridinone (HOPO) and HOPO/hydroxamic acid chelators
Gibson, S., Fernando, R., Jacobs, H. K., & Gopalan, A. S. (2015) · Tetrahedron · doi:10.1016/j.tet.2015.10.031 · Cited by 4
Metabolic and pharmacokinetic evaluation of a Novel 3-hydroxypyridinone iron chelator, CP502, in the rat
Novaković, J., Tesoro, A., Thiessen, J. J., & Spino, M. (2004) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190602 · Cited by 4
Bridging the gap between toxicity and carcinogenicity of mineral fibres by connecting the fibre parameters to the key characteristics of carcinogens: A comprehensive model inspiring asbestos-induced cancer prevention strategies
Gualtieri, A. F., Ferrari, É., Rigamonti, L., Ruozi, B., Mirata, S., Almonti, V., Passalacqua, M., Vernazza, S., Valerio, S. D., Tossetta, G., et al. (2024) · Current Research in Toxicology · doi:10.1016/j.crtox.2024.100202 · Cited by 3
In vitro screening of Fe2+‐chelating effect by a Fenton's reaction–luminol chemiluminescence system
Wada, M., Komatsu, H., Ikeda, R., Aburjai, T. A., Alkhalil, S. M., Kuroda, N., & Nakashima, K. (2014) · Luminescence · doi:10.1002/bio.2628 · Cited by 3
Complexation of hydroxamate-based siderophores with cobalt(II/III): growth inhibitory effect of cobalt(III)-desferricoprogen complex on fungi
Farkas, E., Szabó, O., Gyémánt, G., Szaniszló, S., Szabó, Z., & Pócsi, I. (2018) · Transition Metal Chemistry · doi:10.1007/s11243-018-0225-5 · Cited by 3
Ni(II)-mediated synthesis of the novel tripodal aminopyridyl ligand tamepyr: Coordination geometry and rigidity of complexes with the divalent 3d metals Fe–Zn and with In(III)
Kennedy, D. P., DiPasquale, A. G., Rheingold, A. L., & Planalp, R. P. (2006) · Polyhedron · doi:10.1016/j.poly.2006.08.020 · Cited by 3
Synthesis, characterization and metal coordination of a potential β-lactamase inhibitor: 5-Methyl-2-phenoxymethyl-3- H -imidazole-4-carboxylic acid (PIMA)
Romagnoli, C., Prati, F., Benassi, R., Orteca, G., Saladini, M., & Ferrari, É. (2015) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2015.11.007 · Cited by 3
Basic Principles of Metal Chelation and Chelator Design
Hider, R. C., & Ma, Y. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623892-00024 · Cited by 3
Self-citation
Designing of alternative polymeric nano-chelator for treatment in acute iron poisoning by molecular imprinting approach
Karakoç, V. (2020) · Hacettepe Journal of Biology and Chemistry · doi:10.15671/hjbc.723455 · Cited by 3
Developing Ligands to Target Transition Metals in Cancer
Utterback, R. D., & Tomat, E. (2019) · Wiley eBooks · doi:10.1002/9781119951438.eibc2694 · Cited by 3
Siderophores
Hider, R. C., & Liu, Z. D. (2004) · CRC Press eBooks · doi:10.1081/e-esmc-120012714 · Cited by 3
Self-citation
Synthesis and characterization of some metal complexes of tetracycline, theophylline and cimetidine
Adewale, T. S., & Abosede, O. O. (2026) · Discover Chemistry. · doi:10.1007/s44371-026-00732-3 · Cited by 2
Designing Hydroxamates and Reversed Hydroxamates to Inhibit Zinc‐containing Proteases but not Cytochrome P450s: Insights from Quantum Mechanics and Protein‐ligand Crystal Structures
Barker, C., Lukač, I., & Leach, A. G. (2015) · Molecular Informatics · doi:10.1002/minf.201400171 · Cited by 2
Tris[2-(1,3-thiazol-2-yl-κN)-1H-benzimidazole-κN3]zinc(II) dinitrate ethanol hemisolvate monohydrate at 100 K
de Oliveira, F. L., Huber, P. C., Almeida, W. P., Sabino, J. R., & Aparício, R. (2013) · Acta Crystallographica Section C Crystal Structure Communications · doi:10.1107/s0108270112051372 · Cited by 2
A Dynamic Deferoxamine Polymer with Exceptional Performance in Mitochondrial Iron Depletion and Cytosolic Protein Delivery
Zhu, F., Ren, L., Cheng, W., Zhou, H., Li, Y., Liu, N., Rong, G., Liu, Y., Yu, P., Lv, J., et al. (2025) · Small · doi:10.1002/smll.202412093 · Cited by 2
Antimicrobial Applications of Fe(II) and Fe(III) Schiff Base Complexes: Role of Complexation in Activity Enhancement: A Review (2020–2025)
Alhussaini, M. S., Alyahya, A. A. I., & Al-Ghanayem, A. A. (2025) · Russian Journal of Coordination Chemistry · doi:10.1134/s1070328425600974 · Cited by 2
DNA Binding of a Molecular‐Scale Receptor in the Presence of Zinc( II ) Ions
Benniston, A. C., Harriman, A., Lawrie, D. J., & Mehrabi, M. (2005) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200400813 · Cited by 2
Kinetics and Mechanism of the Formation of (1,5)bis(2-hydroxybenzamido)3-azapentaneiron(III) and Its Reactions with thiocyanate, azide, acetate, sulfur(IV) and Ascorbic Acid in Solution, and the Synthesis and Characterization of (nitrato)bis(2-hydroxybenzamido)3-azapentaneiron(III). The Role of phenol–amide–amine Coordination
Nayak, S., Dash, A. C., Nayak, P. K., & Das, D. (2006) · Transition Metal Chemistry · doi:10.1007/s11243-006-0036-y · Cited by 2
Deferoxamine and other iron chelators
Deravi, N., Norouzkhani, N., Keylani, K., Haghi, S. M., & Rafiei, S. K. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.00591-1 · Cited by 2
Synthesis of gemini triethylene-tetramine bridged bis-tridentate iron(III) chelators
Rodríguez‐Lucena, D., Schalk, I. J., & Mislin, G. L. A. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.01.008 · Cited by 1
Salvage Structures, Known as Iron Chelating Agents, Acquired from the Nature and Matured in the Labs
Lavian, S., Haddadi, F., Farshadfar, E., & Saghaie, L. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673264118231228042816 · Cited by 1
Azo dye-based on-site assay paper kit for rapid and selective naked-eye and smartphone-assisted detection of deferoxamine drug
Koç, Ö. K. (2025) · Talanta · doi:10.1016/j.talanta.2025.128333 · Cited by 1
Physico-Chemical Properties of bis -2-(2-Hydroxyphenyl)-thiazole-carboxamide (BHPTC) Chelators
Hmadeh, M., Mazan, V., Rodríguez‐Lucena, D., Hoegy, F., Platas‐Iglesias, C., Mislin, G. L. A., & Elhabiri, M. (2026) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.5c05413 · Cited by 1
Hypoxia- and inflammation-driven preconditioning modulates angiogenic and metabolic pathways in canine adipose-derived mesenchymal stem cells
Ocampo-Ortiz, P. E., Vallejo-Aristizabal, V., Carvalho, M. G., Stuart, J. B. A. P., Dellaqua, T. T., & Alvarenga, F. D. C. L. E. [. (2026) · PLoS ONE · doi:10.1371/journal.pone.0345360 · Cited by 1
A quantum mechanics and molecular mechanics study of bis-thiosemicarbazones with strong antiplasmodial properties as Fe( iii )-selective chelators and inhibitors of hemozoin formation
Nkungli, N. K., Ayimele, G. A., Tasheh, S. N., Hassan, A. U., & Ghogomu, J. N. (2024) · New Journal of Chemistry · doi:10.1039/d3nj05347d · Cited by 1
Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach
Saeidnia, M., Shadfar, F., Sharifi, S., Babashahi, M., Ghaderi, A., & Shokri, M. (2024) · International Journal of Hematology · doi:10.1007/s12185-024-03825-w · Cited by 1
Synthesis of 3-hydroxy-4-pyridinone hexadentate chelators, and biophysical evaluation of their affinity towards lipid bilayers
Vinhas, S., de Castro, B., & Rangel, M. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107806 · Cited by 1
Recent advances in functionalized macrocyclic polyamines for medicine applications
Chang, H., Qiao, R., & Li, C. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110675 · Cited by 1
An Overview of Multifunctional Metal Chelators as Potential Treatments for Neurodegenerative Diseases
Lewis, F. W., & Tétard, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00020-8 · Cited by 1
Preparation of Nano Triblock Co-polymer for Desferoxiamine Delivery and Cross-Linked Copolymer for Iron Overload Disease
Haddad, A. M., Asadi, I. J. A., & Falih, I. Q. (2017) · Polymer science · doi:10.4172/2471-9935.100020 · Cited by 1
HPO iron chelator, CP655, causes the G1/S phase cell cycle block via p21 upregulation
Tewari, D., Lloyd-Jones, K., Hider, R. C., & Collins, H. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.342 · Cited by 1
Self-citation
Solution Properties of Azidokojatoiron(III) Complexes
Šípoš, R., Šíma, J., Izakovič, M., & Tarapčík, P. (2011) · Journal of Solution Chemistry · doi:10.1007/s10953-011-9721-3 · Cited by 1
Water & O ‐Donor Ligands
Ogden, M. I., & Beer, P. D. (2005) · Encyclopedia of Inorganic and Bioinorganic Chemistry · doi:10.1002/9781119951438.eibc0238 · Cited by 1
Metal ion mediated hydrolysis of4-nitrophenylphosphate in microemulsion media: catalytic versus stoichiometric effects
Eguzozie, K. U. (2008)
Prostate Cancer Evaluation: Design, Synthesis, and Evaluation of Novel Enzyme-Activated Proton MRI Contrast Agents
Yu, J. (2006) · doi:10.21236/ada460803
IN VITRO ANTIOXIDANT AND α-AMYLASE INHIBITION ACTIVITIES OF PANCHSAKAR CHURNA
Ashok Kumar, B. S., Saran, G. S., Banu, F., Harshada, R., & Archana, P. G. (2013) · Acta Medica Medianae · doi:10.5633/amm.2013.0402
Ability of two novel α-amino acid-based tridentate ligands to complex Fe3+ in solution
Kaur, K., & Baral, M. (2014) · Research on Chemical Intermediates · doi:10.1007/s11164-014-1689-3
Image-guided drug delivery using Fe-deferoxamine loaded temperature-sensitive liposomes
Fernandes, A. M. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Modified chitosans for biomedical applications
Yalınca, Z. (2013) · Eastern Mediterranean University Institutional Repository (Eastern Mediterranean University)
Kilogram Scale Synthesis of a Triazine-based Dendrimer and the Development of a General Strategy for the Installation of Pharmacophores to Yield Potential Drug Delivery Agents
Venditto, V. J. (2009) · OakTrust (Texas A&M University Libraries)
Iron Chelating Macromolecules for Intravascular Iron Chelation Therapy
Rossi, N. A. A., & Kizhakkedathu, J. N. (2010) · ACS symposium series · doi:10.1021/bk-2010-1053.ch005
Synthesis and Applications of Non-migratory Metal Chelating Active Packaging
Roman, M. J. (2016) · Scholarworks (University of Massachusetts Amherst) · doi:10.7275/8413210.0
Complex Formation Reactions of Palladium(II) and Amlodipine Drug with Biologically Active Ligands
Al‐Qahtani, S. D., Ammar, R. A. A., Al-Bedair, L. A., & Alshalawi, A. F. (2017) · Asian Journal of Chemistry · doi:10.14233/ajchem.2017.20496
Prospecção de sideróforos do tipo hidroxamato e quinona para terapia de sobrecarga de ferro
da Silva, G. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2019.tde-20082019-160020
WITHDRAWN: Allergic mechanisms of asthma are enhanced during the summer with oxidant PM10 components
Camiña, N., Ho, T.-R., Hawrylowicz, C. M., & Mudway, I. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.08.003
Retracted
Synthesis and Characterization of Second- Generation Iron Pro-chelators
Perez, L. R. (2010) · DukeSpace (Duke University)
THE ROLE OF PARA-AMINOSALICYLIC ACID (PAS) AND N-(2-HYDROXYETHYL) ETHYLENEDIAMINE TRIACETIC ACID (HEDTA) IN ALLEVIATING THE OXIDATIVE CHANGES INDUCED BY MANGANESE NEUROTOXICITY IN ALBINO RATS
ABDOU, K. A., A. MOSELHY, W., SHARKAWY, A. A., S. HUSSIEN, M., & ELHOUDA YASEIN, N. (2012) · Assiut Veterinary Medical Journal/Maǧallaẗ Asyūṭ al-ṭibiyyaẗ al-baytariyyaẗ · doi:10.21608/avmj.2012.173800
Efeito da especiação química sobre a absorção de ferro em Symbiodiniaceae
Romero, J. M. D. (2020) · doi:10.11606/d.46.2020.tde-26042022-100304
Reposicionamento de antirreabsortivos para tratamento da sobrecarga de ferro
Konno, J. T. L. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2023.tde-11122023-142506
Iron–Curcumin–Polyvinylpyrrolidone Nanoparticles With Dynamic Disassembly and Elimination Abilities for Photothermal/Chemo Combinatorial Therapy
Cao, Y., Wang, Y., Zhang, X., Ren, B., Wang, B., & Yang, X. (2025) · Journal of Applied Polymer Science · doi:10.1002/app.57028
Design of nanocarriers for hexadentate 3,4-hydroxypyridinone chelators: A macrophage-targeted strategy to address intracellular infections
Vinhas, S., Moniz, T., Granja, A., de Castro, B., Reis, S., & Rangel, M. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107645
Development and Application of Analytical Strategies to Facilitate Protein-Ligand Binding Analysis on the Proteomic Scale
Wang, D. (2013) · DukeSpace (Duke University)
Opportunities and Challenges for Metal Chemistry in Molecular Imaging: From Gamma Camera Imaging to PET and Multimodality Imaging
Southworth, R., de Rosales, R. T. M., Meszaros, L. K., Ma, M., Mullen, G. E. D., Fruhwirth, G. O., Young, J. D., Imberti, C., Bagunya-Torres, J., Andreozzi, E., et al. (2025) · Advances in inorganic chemistry · doi:10.1016/bs.adioch.2025.09.011
Targeting of the 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase (DXR) enzyme : design and synthesis of new Fosmidomycin analogues as potential herbicides
Midrier, C. (2010) · theses.fr (ABES) · doi:10.70675/b5764d97z2fbbz479ezbf9cz111c959e3a97
Development of chelating materials for localized metal extraction in neurodegenerative diseases
Ariza, J. F. S. (2024) · theses.fr (ABES) · doi:10.70675/f7b37b1dz1608z4009zae5cz453748e7aaaf
Molecular‐Based Magnetic Resonance Multimodal Probes for Tumor Biomarker Imaging
Zhang, J. L., Jiang, M., Xiao, L., Li, S., Liu, Y., Liu, Z. H., Zhang, L., & Chen, S. (2026) · Chemistry - A European Journal · doi:10.1002/chem.71291
Self-citation
Mitochondria-targeted chelators with potential to disrupt iron metabolism in cancer cells: The role of the linker structure in successful membrane translocation
Dobrovolná, T., Tomášková, A., Lamačová, L. J., Cı́sařová, I., Trnka, J., & Kotek, J. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119235
From basic study inspired by the functions of siderophores to applied research
Matsumoto, K., Inomata, T., Ozawa, T., & Masuda, H. (2026) · Coordination chemistry research. · doi:10.1016/j.cocr.2026.100043
Environmental Influence on Neurochemistry
Sharma, A., & Kumar, D. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837071395-00297
BindingDB Entry 50012329: Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities.
BindingDB (2022) · UC San Diego · doi:10.7270/q28p646m
BindingDB Entry 50018683: Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.
BindingDB (2024) · UC San Diego · doi:10.7270/q21n85b2

Authors: Liu, Z. D., & Hider, R. C.
Affiliations: King's College London (GB)
Corresponding author: Hider, Robert C
ORCID: Hider, Robert C
Venue: Coordination Chemistry Reviews
Publisher: Elsevier BV
Published: 2002-10
Volume: 232
Issue: 1-2
Pages: 151-171
ISSN: 0010-8545 (ISSN-L)
DOI: 10.1016/s0010-8545(02)00050-4
OpenAlex: W1990645562
Cited by: 287
References: 132
Citations by year: 2026: 7 · 2025: 10 · 2024: 9 · 2023: 7 · 2022: 10 · 2021: 6 · 2020: 12 · 2019: 10 · 2018: 10 · 2017: 14 · 2016: 13 · 2015: 21 · 2014: 12 · 2013: 24 · 2012: 13
FWCI: 5.68
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Coordination Chemistry Reviews (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
Physical Sciences › Chemistry › Inorganic Chemistry › Inorganic and Organometallic Chemistry
Keywords: iron chelators, iron overload, desferrioxamine B, oral bioavailability, metal ion selectivity, iron(III) complexes, hydroxamate, hydroxypyridinone, triazoles, ligand design, toxicity, bioavailability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Design of iron chelators with therapeutic application

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks